Lushang Freda Pharmaceutical Co.,Ltd. (600223.SS) released a profit for first quarter that Dropped, from the same period last year
The company's bottom line totaled RMB31.896 million, or RMB0.03 per share. This compares with RMB50.711 million, or RMB0.05 per share, last year.
The company's revenue for the period rose 2.8% to RMB900.439 million from RMB876.077 million last year.
Lushang Freda Pharmaceutical Co.,Ltd. earnings at a glance (GAAP) :
-Earnings: RMB31.896 Mln. vs. RMB50.711 Mln. last year.-EPS: RMB0.03 vs. RMB0.05 last year.-Revenue: RMB900.439 Mln vs. RMB876.077 Mln last year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.